Neural Bases of Post-stroke Emotion Perception Disorders (STROKEM)

October 21, 2022 updated by: University Hospital, Lille
This monocentric physiological study will evaluate the neural bases of visual recognition of emotions in stroke patients vs. healthy controls using MRI (functional and structural connectivity) and EEG.

Study Overview

Status

Not yet recruiting

Detailed Description

This monocentric physiological study will evaluate the neural bases of visual recognition of emotions in stroke patients vs healthy controls (2 groups of 40 subjects). It will include functional MRI, structural MRI (disconnectome), EEG, and behavioral assessments of emotion recognition and executive functions.

Study Type

Observational

Enrollment (Anticipated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patient group: 40 subjects Healthy control group: 40 subject

Description

Inclusion Criteria:

Stroke group:

  • Man or Woman
  • Age 18-80y
  • Unique stroke, ischemic or hemorrhagic
  • at the chronic phase (< 6 months)
  • Written informed consent
  • subject having a social insurance
  • Subject who consent to complete all the study's experiments

Healthy controls group:

  • Man or Woman
  • Age 18-80y
  • No history of neurological or psychiatric disease.

Exclusion Criteria:

Stroke group

  • Subject who is unable to consent (due to dementia, severe aphasia, psychiatric disorder...)
  • History of other neurologic disorders
  • Significant le vel of depression or anxiety, assessed by the STAI and the BDI questionnaires
  • Non corrected visual loss
  • Subjects suffering from visual neglect (assessed by the Bells Test and a bisection test (20mm)
  • contra-indications to MRI
  • pregnant or breastfeeding woman
  • Women of childbearing age without effective contraception

Healthy controls group

  • Subject who is unable to consent (due to dementia, severe aphasia, psychiatric disorder...)
  • History of neurologic disorders
  • Significant level of depression or anxiety, assessed by the STAI and the BDI questionnaires
  • Non-corrected visual loss
  • contra-indications to MRI
  • pregnant or breastfeeding woman
  • Women of childbearing age without effective contraception

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Stroke
Stroke patients (ischemic or hemorrhagic) in the chronic phase (> 6 months)
Healthy controls
Healthy adult controls

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BOLD signal when fear visual recognition
Time Frame: 1 day
Compare correlations of cerebral functional activations (BOLD) by fMRI between groups when stimulus = fear
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BOLD signal when happiness visual recognition
Time Frame: 1 day
Compare correlations of cerebral functional activations (BOLD) by fMRI between groups when stimulus = happiness
1 day
Electrical connectivity (EEG) when fear visual recognition
Time Frame: 1 day
Compare cerebral networks activated by a fear visual task recognition in both groups
1 day
Electrical connectivity (EEG) when fear happiness visual recognition
Time Frame: 1 day
Compare cerebral networks activated by a happiness visual task recognition in both groups
1 day
Electrical connectivity (EEG) when emotions auditory recognition
Time Frame: 1 day
Compare cerebral networks activated by an auditory task recognition in both groups
1 day
Relationship between behavioral performance and cerebral networks
Time Frame: 1 day
Correlations between fMRI and EEG networks vs. behavioral performance (emotion recognition)
1 day
Structural connectivity
Time Frame: 1 day
Disconnectome maps in the stroke patients group
1 day
Relationship between emotional self-assessment and cerebral networks
Time Frame: 1 day
Correlation between the ESQ (emotional state questionnaire) and cerebral connectivity (EEG) and fMRI networks
1 day
Relationship between the behavioural performance in emotion recognition and executive functions
Time Frame: 1 day
Correlation between behavioral performance in emotion recognition (Eckman Test) and executive functions (Stroop Test) in the stroke group
1 day
Relationship between lesion characteristics and the behavioral performance in emotion recognition
Time Frame: 1 day
Correlation between lesion volume and the behavioural performance in emotion recognition (Eckman Test)
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2022

Primary Completion (Anticipated)

October 1, 2025

Study Completion (Anticipated)

October 1, 2025

Study Registration Dates

First Submitted

October 18, 2022

First Submitted That Met QC Criteria

October 21, 2022

First Posted (Actual)

October 26, 2022

Study Record Updates

Last Update Posted (Actual)

October 26, 2022

Last Update Submitted That Met QC Criteria

October 21, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

3
Subscribe